{
  "docId": "019de074-b790-710b-959d-3b3968058456",
  "docSlug": "1d5b8b95ea2ab7306d438b9aa5c4afa8",
  "documentTitle": "Kinnevik | Results Presentation Deck | 16 slides",
  "authorId": "kinnevik",
  "authorName": "Kinnevik",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.4446952,
  "pageNumber": 6,
  "pageCount": 16,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "other",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "Includes a timeline-style visual showing capital deployment from 2020-2023.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de074-b790-710b-959d-3b3968058456/6",
  "deckHref": "/decks/019de074-b790-710b-959d-3b3968058456",
  "deckJsonHref": "/decks/019de074-b790-710b-959d-3b3968058456.json",
  "deckAnchorHref": "/decks/019de074-b790-710b-959d-3b3968058456#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.82
      },
      "kind": "callout",
      "text": "The return on our Livongo/Teladoc investment has financed our capital deployment into new Healthcare businesses over 2020-23, maintaining a center of gravity in the venture and growth section of the business maturity S-curve",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4fc1bcb6-c751-4695-ab39-6040817818fa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.52,
        "y": 0.28
      },
      "kind": "chart",
      "text": "Timeline of investments from 2020 to 2023 including Cityblock, Spring Health, Transcarent, Recursion, and Enveda.",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0377764f-fd09-4a7b-add8-925f264daa01",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.03,
        "y": 0.26
      },
      "kind": "list",
      "text": "In Q1, we exited our remaining stake in Teladoc. This is the first significant full exit in the Growth Portfolio generating a >55% IRR on an aggregate SEK 1.4bn investment over a six-year tenure starting with our Livongo investment in 2017.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "791e1ce0-c382-458f-94d5-a9bd392fd85b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.03,
        "y": 0.42
      },
      "kind": "list",
      "text": "Of SEK 5.4bn in total proceeds, we have redeployed 4.6bn into a number of new businesses with a current carrying value of 7.0bn.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f039219-5dab-40fa-9a8f-f81c35621abe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.03,
        "y": 0.59
      },
      "kind": "list",
      "text": "Going forward, we remain focused on three areas of investment within healthcare: 1. technology-enabled care delivery, 2. software healthcare enablers, 3. life sciences businesses.",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb106cb3-dc1c-4f8f-971a-84b6fd782078",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.94,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "OUR TELADOC EXIT REALIZES A >55% IRR INVESTMENT, WITH GAINS REALLOCATED INTO NEW CARE DELIVERY MODELS AND OUR ENTRY INTO LIFE SCIENCES",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbe024a7-a8d5-4eb9-8543-4f2a154ed98f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.22,
        "x": 0.39,
        "y": 0.0017
      },
      "kind": "title",
      "text": "Rotating Out Of Teladoc\nCapital Reallocation in Healthcare",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31462bcd-5ff9-4de6-84bd-7df58b4659ab",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "capital-allocation-framework",
      "slug": null,
      "matchId": "0aa6bf37-57cb-4825-96ad-d6a758359eec",
      "evidence": "Describes exiting one asset to redeploy capital into new growth areas.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 7,
      "from": 5,
      "beatId": "a4788368-7730-41ec-9d75-284483591beb",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The slides on investments, such as the follow-on investment into Spring Health and the exit from Teladoc, present the solution and approach",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}